Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Freeman

Showing results (121-130 of 191) with videos related to

Pageof 20
Sort By:
Endocrine-Related Cancer|November 12, 2025
ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignanciesMichael R Freeman, Lillian M Perez, Qian Yang, et al.
Prostate Cancer and Prostatic Diseases|December 29, 2017
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE studyJuzar Jamnagerwalla, Lauren E Howard, Emma H Allott, et al.
Cancer Research|January 25, 2003
A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinomaRosalyn M Adam, Theodora Danciu, Dawn L McLellan, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 31, 2024
ONECUT2 is a druggable driver of luminal to basal breast cancer plasticityIrene Zamora, Mirian Gutiérrez, Alex Pascual, et al.
Cancer Biology & Therapy|September 6, 2007
Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progressionDolores Di Vizio, Federica Sotgia, Terence M Williams, et al.
Plos One|July 7, 2012
The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing networkJayoung Kim, Dolores Di Vizio, Taek-Kyun Kim, et al.
RNA Biology|November 19, 2016
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patientsAndrew Conley, Valentina R Minciacchi, Dhong Hyun Lee, et al.
Scientific Reports|August 24, 2016
Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCsYing Qu, Bo Zhou, Wei Yang, et al.
Nucleic Acids Research|January 10, 2023
ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics studyMaria V Luna Velez, Hannah K Neikes, Rebecca R Snabel, et al.
Cancer Research|March 5, 2009
Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translationNishit K Mukhopadhyay, Jayoung Kim, Bekir Cinar, et al.
Pageof 20

Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
Endocrine-Related Cancer|November 12, 2025
ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignanciesMichael R Freeman, Lillian M Perez, Qian Yang, et al.
Prostate Cancer and Prostatic Diseases|December 29, 2017
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE studyJuzar Jamnagerwalla, Lauren E Howard, Emma H Allott, et al.
Cancer Research|January 25, 2003
A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinomaRosalyn M Adam, Theodora Danciu, Dawn L McLellan, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 31, 2024
ONECUT2 is a druggable driver of luminal to basal breast cancer plasticityIrene Zamora, Mirian Gutiérrez, Alex Pascual, et al.
Cancer Biology & Therapy|September 6, 2007
Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progressionDolores Di Vizio, Federica Sotgia, Terence M Williams, et al.
Plos One|July 7, 2012
The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing networkJayoung Kim, Dolores Di Vizio, Taek-Kyun Kim, et al.
RNA Biology|November 19, 2016
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patientsAndrew Conley, Valentina R Minciacchi, Dhong Hyun Lee, et al.
Scientific Reports|August 24, 2016
Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCsYing Qu, Bo Zhou, Wei Yang, et al.
Nucleic Acids Research|January 10, 2023
ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics studyMaria V Luna Velez, Hannah K Neikes, Rebecca R Snabel, et al.
Cancer Research|March 5, 2009
Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translationNishit K Mukhopadhyay, Jayoung Kim, Bekir Cinar, et al.
Pageof 20